Amanote Research
Register
Sign In
Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy?
Diabetes Care
- United States
doi 10.2337/dc11-2282
Full Text
Open PDF
Abstract
Available in
full text
Categories
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Date
May 7, 2012
Authors
D. Chalk
M. Pitt
B. Vaidya
K. Stein
Publisher
American Diabetes Association
Related search
Antiphospholipid Syndrome
Antiphospholipid Syndrome
Japanese Journal of Thrombosis and Hemostasis
Antiphospholipid Syndrome
Japanese Journal of Thrombosis and Hemostasis
Antiphospholipid Syndrome
Antiphospholipid Antibody Syndrome
Obstetric Antiphospholipid Syndrome
Lupus Science and Medicine
Medicine
Immunology
Neonatal Antiphospholipid Syndrome
Antiphospholipid Antibody Syndrome
Catastrophic Antiphospholipid Syndrome (CAPS)
Best Practice and Research in Clinical Rheumatology
Medicine
Rheumatology
Editorial: Antiphospholipid Syndrome (APS)
Open Urology and Nephrology Journal
Urology
Nephrology